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Hippo pathwayAlthough the expression of the neuronal apoptosis inhibitory protein (NAIP) gene is considered
involved in apoptosis suppression as well as in inﬂammatory response, the molecular basis of the
NAIP gene expression is poorly understood. Here we show that the TEA domain protein 1 (TEAD1)
is able to positively activate the transcription of NAIP. We further demonstrate that this regulation
is mediated by the presence of the endogenous Yes associated protein (YAP) cofactor, and requires
the interaction with YAP. We ﬁnally identiﬁed an intronic region of the NAIP gene responding to
TEAD1/YAP activity, suggesting that regulation of NAIP by TEAD1/YAP is at the transcriptional level.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The neuronal apoptosis inhibitory protein (NAIP), the ﬁrst
member of the inhibitor of apoptosis proteins (IAPs) family, was
shown to be absent in patients with severe forms of spinal muscu-
lar atrophy (SMA) [1]. Further studies revealed that this protein
renders cells resistant to apoptosis under both in vivo and
in vitro conditions [2–4]. NAIP, a 160 kDa protein, has three regions
of baculoviral inhibitor of apoptosis repeat (BIR) domains, a nucle-
otide binding oligomerization domain (NOD), and a leucine rich re-
peat (LRR) motif. Anti apoptotic function of NAIP is attributed to its
BIR3 domain that inhibits caspase-9 and to its BIR2 domain that
inhibits caspase-3 [5,6]. Nevertheless, thanks to the presence of
the NOD domain and LRR motif, which is unique among the IAPs,
it has been suggested that NAIP functions are distinct from these
of other IAP proteins by harbouring these domains [7], and it has
been proposed to act as modulator in assembling the ‘‘inﬂamma-some’’, a cytoplasmic protein complex, for the activation of inﬂam-
matory caspases in response to several stimuli [8,9]. These
different biological functions proposed for NAIP could be taken into
account by different regulation mechanisms, based, for example,
on different spliced variants, as described [10], and reported on
the NCBI site (provided by RefSeq, Jul 2008).
We recently showed that alteration of TEA domain protein 1
(TEAD1) expression levels confers apoptotic resistance in HeLa
cells, through transcriptional up-regulation of another member of
the IAP family, Livin [11]. In that same paper we also show that
NAIP is up- and down-regulated according to similar variation of
TEAD1 expression levels, suggesting a positive regulation of NAIP
by TEAD1. TEAD1 belongs to the family of conserved eukaryotic
transcription factors (TEAD proteins), characterized by the TEA/
ATTS DNA binding domain [12–14], that, in mammals, includes
four closely related Tead genes (Tead1 to Tead4) [15,16]. The tran-
scriptional activator function of the TEAD proteins appears to re-
quire their interaction with coactivator proteins [17]. One of the
well characterized, in vitro and in vivo, cofactor of mammalian
TEAD proteins is the Yes-associated protein (YAP) [18–21]. YAP is
the effector of the Hippo tumour suppressor pathway that restricts
organ growth by keeping in check cell proliferation and promoting
apoptosis in mammals and also in Drosophila [22,23].
To gain insights on the transcriptional regulation of NAIP, based
on our previous data [11], we decided to study the role of the
transcription factor TEAD1 and its relationship with YAP and the
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inducible cellular Tet-On system we show a positive TEAD1-
dependent induction of the expression of the NAIP gene. Moreover,
we show that this induction needs the presence of endogenous YAP
as well as the interaction with this transcriptional co-factor, and
that the Hippo pathway could interfere with this regulation. We ﬁ-
nally identify several intronic regions of NAIP containing putative
DNA binding motifs for TEAD proteins. Interestingly we show that
one of these regions, intron 11, contains a TEAD1 tandem cis-regu-
latory binding element and responds to TEAD1/YAP transcriptional
activity suggesting that regulation of NAIP by TEAD1/YAP is at the
transcriptional level.
2. Materials and methods
2.1. RNA extraction and quantitative RT-PCR
Total RNA extraction, cDNA synthesis and real-time PCR were
performed as described previously [24]. Ampliﬁcation of the GAP-
DH and RPL13 genes were performed to ensure comparability be-
tween cDNAs from different samples. Primers and annealing
temperatures for GAPDH, RPL13, TEAD1, YAP and NAIP ampliﬁcation
were reported in [11]. For each gene, values were averaged over at
least three independent measurements. Three independent RNA
isolation experiments were performed for all experiments, and
means were calculated. To estimate the signiﬁcance of the differ-
ences between means, the parametric statistical Student’s t-test
was used.
2.2. Cells, plasmids and transfection conditions
HeLa and HeLa T-Rex (Invitrogen), MCF7 and BUA cells growth
conditions and the following plasmids (TEAD1, TEAD1-Y421H,
TEAD1 D55-121, YAP and TEAD-VP16) were previously described
[11]. 106 cells were transfected with a total amount of 2400 ng of
DNA. Cells were transfected either with 2400 ng of pXJ40 empty
vector (controls) or with equal amounts of indicated expressing
plasmids (800 ng per construct). The total amount of transfected
DNA was kept constant by addition of empty vector (pXJ-40) wher-
ever necessary. MST2 and LAST1 cDNAs (gifts from X. Yang) were
subcloned into the pcDNA3.1 vector to allow expression of these
cDNAs under the control of a CMV promoter. The genomic region
of intron 11 of NAIP was ampliﬁed by PCR (forward primer 50
CCGCTCGAGCGGTCCTTAGAAGCACCAATCAGT reverse primer
CCGCTCGAGCGGCCAGATCGGAAGAGATATC) and subsequently
cloned into pLG3-TK (gift of A. Payne). A 53 bp fragment from
the promoter of the 3b-hydroxysteroid dehydrogenase-isomerase
(3bHSD) gene was cloned into the pGL3-TK plasmid. This 53 bp re-
gion of the 3bHSD promoter contains binding sites for the TEAD
factor. Luciferase assays were performed as described previously
[11]. All experiments were performed at least three times.
2.3. Tet-On TEAD1 clones
To obtain inducible clones expressing TEAD1, we used the T-
REX Tetracycline-Regulated Expression System for Mammalian
Cells (Invitrogen), according to the manufacturer’s instruction.
Brieﬂy, the HeLa T-Rex cell line was transfected with pcDNA 4/
TO in which the TEAD1 cDNA was cloned. Selection of resistant
clones was performed with an optimal dose of antibiotic (400 lg/
ml of Zeocin), assessed during a previous toxicity assay. Following
ampliﬁcation, the clones were treated with 1 lg/ml of doxicycline
to assess the induction of TEAD1. Seven independent clones were
found positive to induction, and 2 were chosen for subsequent
experiments.2.4. siRNA
siRNA against YAP or negative-control RNA were chemically
synthesized (Dharmacon Research, Lafayette, USA). Synthetic siR-
NAs were transfected with TransIT-TKO Transfection Reagent
(Euromedex) according to the manufacturer’s instructions.
2.5. Western blot analyses
Western blot analyses were performed as described previously
[11].
2.6. ChIP experiments
Subconﬂuent cells grown in ﬁve 150-mm plates were ﬁxed
in situ with 1% Formaldehyde for 10 min at room temperature,
then ﬁxation was blocked with 125 mM glycine, cells were rinsed
and scrapped in PBS. Cells were ﬁrst lysed in Lysis buffer A (50 mM
Hepes pH 7.5, NaCl 140 mM, EDTA 1 mM, glycerol 10% NP-40 0.5%
and Triton X-100 0.25%), then centrifugated and rinsed in lysis buf-
fer B (Tris 10 mM pH 7.5, NaCl 200 mM, EDTA 1 mM, EGTA
0.5 mM), centrifugated again and ﬁnally resuspended in lysis buf-
fer C (Tris 10 mM pH 7.5, NaCl 100 mM, EDTA 1 mM, EGTA
0.5 mM, Na–deoxycholate 0.5%, N-lauryl sarcosine 0.5%). Chroma-
tin was sheared in a Bioruptor sonicator, used at high power with
30/30 s cycles for 20 min, then 1% Triton X-100 was added to ly-
sates, and cell debris were centrifugated. In parallel, 30 lg anti-
YAP or anti-TEF1 were incubated with 200 ll ProteinG Dynabeads
for 4 h in PBS containing 0.1% BSA. Lysates were incubated with the
beads overnight, beads were then washed ﬁve times in wash buffer
(50 mM Hepes pH 7.6, 500 mM LiCl, 1 mM EDTA, 0.7% Na–deoxy-
cholate, 1% NP-40) and once in TBS. DNA–protein complexes were
then eluted in 10 mM Tris pH 8, 1 mM EDTA, 1% SDS at 65 C for
15 min. Crosslinked was reversed at 65 C overnight, then recov-
ered DNA was treated with RNase, proteinase K and puriﬁed using
phenol–chloroform extraction. qPCR analysis was then carried on
using Input samples subjected to the same procedure as controls.
Primers for Q-PCR are listed in Table S1B.
2.7. Electrophoretic mobility shift assay (EMSA)
The sequences of double-stranded oligonucleotides end-labeled
with biotin (Sigma) are listed in Table S1C. EMSA analysis was per-
formed according to the Thermo Scientiﬁc LightShift Chemilumi-
nescent EMSA Kit.
3. Results
3.1. TEAD1 positively regulates NAIP expression and depends on
endogenous YAP expression
Very little is known about the regulation of the NAIP gene that
could be explained, at least partially, by the extreme repetitiveness
and complexity of the genomic organisation of the region contain-
ing the gene in humans, as previously reported [25].
For this reason, to gain insight on the regulation of NAIP, we
took advantage of our previously published data [11] where we
showed that overexpression or inhibition of TEAD1 expression in
HeLa cells resulted in a increase or decrease in the level of endog-
enous NAIP mRNA, suggesting a positive regulation of NAIP by
TEAD1. Since the overexpression experiment was performed
through transfection of high amounts of TEAD1 plasmid, we
decided to perform Tet-On clones with the T-REx™ HeLa cell lines
(Invitrogen), allowing a more physiologically and well monitored
induction of TEAD1 expression levels. Namely, using this technique
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Fig. 1. TEAD1 positive regulation of NAIP expression depend on endogenous YAP expression. (A) RT-Q-PCR quantiﬁcations for the transcripts of the TEAD1 and NAIP genes
were performed on 105 T-REx™ HeLa cells (clone 7 and 12), in the presence (form 1 h to 48 h) or absence of 1 lg/ml of Doxicycline. TEAD1 and NAIPmRNA quantiﬁcation were
normalized to endogenous GAPDH mRNAs for internal control. Values obtained for control transfection are normalized to 1 for each gene. Histograms display mean values
from a minimum of three independent replicates. Error bars indicate S.D. Asterisks indicates statistical signiﬁcance. The P values were calculated by the Student’s t-test from
three independent experiments. ⁄⁄P < 0.01. (B) Western blot analysis of lysates from HeLa cells treated with 1 lg/ml of doxicycline for 24 h and 48 h (clone 7). TEAD1 and
actin levels are presented. (C) Relative mRNA levels for TEAD1 and YAP genes in HeLa cells. GAPDH served as internal control to normalize the TEAD1 and YAP mRNAs. TEAD1
levels are set to 1. ⁄⁄P < 0.01, t-test. (D) Western blot analysis of lysates from HeLa cells treated with siRNA (random or YAP). TEAD1, YAP and actin levels are revealed. (E–G)
RT-Q-PCR quantiﬁcations for the transcripts of the YAP, TEAD1 and NAIP genes were performed on T-REx™ HeLa cells (clone 7) in the presence (for 5 or 24 h) or absence of
doxicycline and treated with 10 nM of random or YAP-speciﬁc siRNA.
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of TEAD1 by adding the antibiotic doxicycline. We obtained several
positive inducible clones, and we decided to focus our study on
two representative clones (7 and 12). We observed in both clones
(Fig. 1A) a rapid induction of the mRNA (measured by RT-Q-PCR) of
TEAD1 after 1 h induction, with a maximum obtained at 5 h. Wes-
tern blot analysis revealed 24 and 48 h after induction, an increase
also in the level of the TEAD1 protein in treated cells versus control
cells (Fig. 1B). Interestingly, this induction is well correlated with
an increase of NAIP mRNA, starting at 3 h of treatment (Fig. 1A).
It is worth stressing that this induction is increased after 24 h of
induction, according to the observed increase TEAD1 levels. This
result, together with our previous data [11] showing that a de-
crease of TEAD1 by siRNA correlates positively with a signiﬁcant
decrease (65–70%) of NAIP mRNA, suggests that expression of NAIP
can be modulated positively by TEAD1.
However, it is well established that TEAD1 must interact with
cofactors to activate transcription [26,27]. The fact that expression
of NAIP is rapidly induced (3 h) after TEAD1 induction, suggests
that this cofactor must still be present, and in sufﬁcient amount,
in the cells when doxicycline is added. Since one of the main cofac-
tors of TEAD1 is the transcriptional co-activator YAP [18,20], and
since RT-Q-PCR analysis of endogenous YAP expression in HeLa
cells showed very high levels (20-fold) of mRNA when compared
to TEAD1 expression (Fig. 1C), we focused our attention on YAP
for further analyses. To asses if YAP expression is necessary for
TEAD1 to induce NAIP expression, we examined the effect of a de-
crease of mRNA of YAP on TEAD1-dependent NAIP induction. Spe-
ciﬁc mRNA knockdown by a combination of four independent
synthetic siRNAs reduced YAP mRNA by 75–80% in clone 7
(Fig. 1E) and in clone 12 (data not shown). Western blot analysis
showed also a reduction at the protein level of YAP (Fig. 1D), whileA
C
0,0
0,5
1,0
1,5
2,0
2,5
3,0
3,5
4,0
4,5
R
el
at
iv
e 
ex
pr
es
si
on
 le
ve
l 
   
   
   
of
 N
AI
P 
ge
ne
Control        TEAD1     TEAD1/YAP  TEAD1-H   TEAD-H/YAP
B
0,0
1,0
2,0
3,0
4,0
5,0
6,0
7,0
Control TEAD1 YAP
R
el
at
iv
e 
ex
pr
es
si
on
 le
ve
l 
   
   
   
of
 N
AI
P 
ge
ne
TEAD1/YAP TEAD1/YAP (2X) 
Fig. 2. Interaction of TEAD1 with YAP is required for NAIP activation and is affected by the
(B) transfected with 800 ng of the pXJ40 empty plasmid (control), TEAD1 or YAP-expressin
in combination. mRNA quantiﬁcation was normalized to endogenous GAPDH mRNAs for
displayed. ⁄P < 0.05, ⁄⁄P < 0.01, t-test.the endogenous level of TEAD1 remains unchanged (Fig. 1D). When
treated with doxicycline, HeLa clones showed, as expected, a time-
dependent increase of TEAD1 expression (Fig. 1F), and this inde-
pendently of the endogenous YAP levels. Moreover, we observed
that without induction of TEAD1 (point 0 h), the basal expression
of NAIP is reduced when YAP is knocked-down (Fig. 1G), suggest-
ing that endogenous YAP is required for NAIP expression. To fur-
ther conﬁrm this observation, we also knocked down YAP protein
in another cellular model, the BUA cells (a human ﬁbroblast cell
line), whose levels of endogenous YAP are higher when compared
to HeLa cells (Fig. S1A). Interestingly, a decrease of mRNA and pro-
tein levels of endogenous YAP (Fig. S1B and C) is correlated to a sig-
niﬁcant decrease of endogenous NAIP mRNA level (Fig. S1D),
according with results observed in HeLa cell line.
Finally, when HeLa cells were treated with doxicycline, the
induction of NAIP expression was completely abolished, when
YAP was knocked-down (Fig 1G). Taken together, these results
indicate that the presence of endogenous YAP is required for
basal expression as well as TEAD1-dependent induction of NAIP
expression.
3.2. Interaction of TEAD1 with YAP is required for NAIP activation and
is affected by the Hippo pathways
The biochemical nature of the YAP–TEAD interaction, that is
crucial to mediate YAP-induced gene expression, has been recently
reported [28,29]. To investigate whether YAP/TEAD1 interaction is
involved in NAIP up-regulation by TEAD1, two strategies were
used. In one approach, TEAD1 was overexpressed with YAP in HeLa
cells. Western blot analysis of lysates from HeLa cells transfected
with a void plasmid (control), TEAD1 and/or YAP were performed,
and TEAD1, YAP and actin levels were revealed. As shown inR
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Fig. 3. TEAD1 transcriptionally regulate NAIP expression. (A) Structural features of
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⁄P < 0.05, ⁄⁄P < 0.01.
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alone or with YAP, versus control cells transfected with a void plas-
mid are observed. Similar results were obtained with YAP or YAP/
TEAD1 transfected cells (Fig. S1E). As previously published [11], we
observed a slight, but signiﬁcant, increase in NAIP expression,
when TEAD1 was overexpressed (Fig. 2A). When YAP was overex-
pressed alone, no effect on NAIP induction was observed (Fig. 2A).
On the contrary, when TEAD1 and YAP were co-expressed, TEAD1-
dependent NAIP induction was increased in a dose dependent
manner (Fig. 2A), indicating a cooperative effect of these two pro-
teins on NAIP expression. In order to conﬁrm this observation we
overexpressed TEAD1 and/or YAP in the MCF7 cell line (a cell line
derived from Human mammary tumors), whose levels of endoge-
nous TEAD1 and YAP proteins are very low when compared to
HeLa cells (Fig. S1A). Consistent results were obtained after overex-
pression of TEAD1, with a slight, but signiﬁcant induction of NAIP
(Fig. 2B). Interestingly when both TEAD1 and YAP were co-ex-
pressed, TEAD1-dependent NAIP induction was increased
(Fig. 2B), indicating a cooperative effect of these two proteins on
NAIP expression, as observed in HeLa cells. In the second approach,
we analyzed in parallel how a mutant TEAD1 protein unable to
interact with YAP affects NAIP induction. Advantage was taken of
the mutation of a highly conserved tyrosine in the YAP-binding do-
main of TEAD1, (TEAD1–Y421H, hereafter referred to as TEAD1-H)
(Fig. 3A). This mutation causes the human genetic disease known
as Sveinsson’s chorioretinal atrophy [30], and strongly reduces
both YAP/TEAD1 interaction and activity [28]. Contrary to wild-
type TEAD1, TEAD1-H was unable to activate the expression of a
TEAD1 responsive reporter when transfected with YAP, as previ-
ously published [11] conﬁrming that interaction with YAP is se-
verely impaired. HeLa cells transfected with the mutant forms of
TEAD1 showed no induction of NAIP expression levels (Fig. 2C),
suggesting that interaction with endogenous YAP is required for
NAIP induction. According to this result, the cooperative effects ob-
served with YAP and TEAD1 on NAIP induction were prevented
with TEAD1-H (Fig. 2C) indicating that they rely on the TEAD1/
YAP interaction. Altogether, the results obtained with transfection
of YAP and TEAD-H, which is unable to interact with YAP, clearly
indicate that the TEAD1-dependent NAIP up-regulation requires
the interaction with YAP.
It is well established that YAP activity is regulated through its
shuttling between the nucleus and the cytoplasm, under the con-
trol of the Hippo pathway. Indeed, activation of the Hippo pathway
leads to YAP phosphorylation, by the large tumour suppressor-1
(LATS1) kinase, and its exclusion from the nucleus. [31–33]. To
investigate whether the Hippo pathway is involved in NAIP up-reg-
ulation by affecting TEAD1/YAP interaction, we overexpressed
TEAD1 with both core components of the Hippo pathway, mamma-
lian Ste20-like-2 (MST2) and LATS1 kinases. When MST2 and
LATS1 were overexpressed, a slight but signiﬁcant decrease of NAIP
mRNA was observed (Fig. 2D). This results is consistent with the
fact that endogenous YAP is required for TEAD1-dependent NAIP
induction, as observed when YAP is knocked-down (Fig. 1C). Inter-
estingly, when MST2 and LATS1 were co-expressed with TEAD1,
NAIP induction was completely abolished, with a signiﬁcant de-
crease of its expression, compared to TEAD1 (Fig. 2D), suggesting
that an active and nuclear form of endogenous YAP is required
for the TEAD1-dependent NAIP induction.
3.3. TEAD1 transcriptionally regulates NAIP expression
Consistent with our observations, there has been speculation
that the expression of NAIP may be directly regulated by TEAD1.
The human NAIP locus (NCBI Reference Sequence No.
NG_008724.1) was therefore examined for putative TEAD binding
sites using the Cis-element Cluster Finder (CISTER) program (http://zlab.bu.edu/~mfrith/cister.shtml). As positive control, we checked
the promoter of the human chorionic somatomammotropin (hCS)
gene that is known to respond to the TEAD transcription factor
[34]. As expected, analysis of this sequence for TEAD binding sites
showed several, highly signiﬁcant binding sites in this region (data
not shown). Initial screening of the NAIP genomic region with the
CISTER program revealed ﬁve signiﬁcantly TEAD-rich regions within
introns 3 (713 bp), 9 (1528 bp), 11 (705 bp) and 12 (340 bp), as
well as in exon 9 (1312 bp) (Fig. 4A). Attention was focused on in-
tronic regions. Of the four introns, intron 11 was selected for fur-
ther analyses, because it showed a higher number of putative
sites (27) (Table S1A) compared to introns 3 and 12, and because
the length of the genomic region is shorter compared to intron 9.
The genomic fragment, corresponding to the intron 11 TEAD-rich
region of NAIP was ampliﬁed by PCR and cloned into the pGL3-
TK plasmid, in order to obtain a luciferase reporter construct
(Int.11). As positive control, we cloned in the same vector a
53 bp fragment from the promoter of the 3b-hydroxysteroid
Possible functional cis-elements for TEAD in NAIP genomic DNA
ATG
Intron 3 Intron 9 Intron 11 Intron 12Exon 9
TEAD
A
B
C
taaacttctttcctgagatttttatttttattcattttattttattttattttatttgagacagggtcttacttt
gtcaccctaggctggaatgcaatggcaagatcatggctcactgcagcgtcgacctcccaggctcaagtgatcctc
ccatctcagcctccccagtagctgggaccacaagcatgtgccaccacacctggctaatttttgtattttttgtag
agacagggttttgccatgttggccaggctggtcttgaactcctaggctcaagcaattcgcctgcctcggtctccc
acagtgctgggattacaggcatgagtcactttgcctggcctctttcctgagatgcatggtgcttatgataagcac
acattatgtctaggtccctgcttcaagtgtggcactttggacacatgctttccacattccgattttgtgccaaaa
cctatgagatgattgcaatgtgggaatcatggatggctgtggaaaatcctaacacattcgtagtagacaggcaga
atcatggaatgaaaaggcatggcgttcagactgagggagatgtgactatgaatccctgttgtgcccccctttctt
tctctccacagaaatggcacagggtgaagcccagtggtttcaagaggcaaagaatctgaatgagcagctgagagc
agcttataccagcgccagtttccgccacatgtctttg
Nuclear extract 
Probe T1-T2
Competitor
Free Probe
Shift
Cytoplasmic extract - - - +
- + - -
+ + + +
- + + -
T1
T2
Fig. 4. Possible functional cis-elements for TEAD in NAIP genomic DNA. (A) Possible functional cis-elements (in red) for TEAD in NAIP genomic DNA are assessed by using the
Cis-element Cluster Finder (Cister) program. Positions of starting codon (ATG) and intron/exon regions are indicated. (B) Alu sequence of about 300 bp, in yellow, in the intron
11 sequence is showed. The 27 possible functional cis-elements for TEAD in the intron 11 sequence are underlined. The four cis-elements with the higher probability are
showed in green. (C) EMSA using nuclear extracts (8 lg proteins) obtained from HeLa cells transfected with TEAD1 plasmid. Controls include: BSA (lane 1), competitor (lane
2) and cytoplasmic extract (lane 4).
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contains binding sites for TEAD factors [35].
To investigate whether TEAD1-dependent NAIP induction is
mediated through the transcriptional activity of TEAD1, a constitu-
tively active form was used [11] where its YAP binding domain
[19] is replaced by the activation domain (AD) of VP16 (TEAD-
VP16) (Fig. 3A). When this constitutively active form was co-tran-
fected with the native plasmid pGL3-TK, no induction was ob-
served compared to plasmid pGL3-TK alone (Fig. 3B). Conversely,
as expected, the TEAD-VP16 fusion protein highly stimulated the
TEAD-responsive reporter construct, 3bHSD (Fig. 3B). Interestingly,
overexpression of TEAD-VP16 with the NAIP-Intron11 containing
plasmid resulted in a 6-fold reporter activation, compared to the
control (Fig. 3B). To conﬁrm this results we transfected HeLa cell
line with the NAIP-intron 11 luciferase construct, together with
TEAD1 and/or YAP. According to results obtained with endogenous
NAIP mRNA, we observed a 2.5fold induction of luciferase activity
with TEAD1 alone and no signiﬁcant effect with YAP. Most impor-
tantly, a high increase (10-fold) in luciferase activity was observed
when TEAD1 and YAP are co-expressed (Fig. 3C). These results con-
ﬁrmed the results observed with TEAD-VP16, and strongly suggest,
in agreement with the endogenous NAIP induction experiments,
that TEAD1 and YAP regulate transcription of NAIP rather than
its mRNA stability.
The intron 11 of NAIP contains 27 possible functional cis-ele-
ments for TEAD (Fig. 4B and Table S1A). The presence of an Alu
repeated sequence (of about 300 bp) at the 50 of the intron
(Fig. 4B) impeded the analysis of this region by using Chip exper-
iments. We therefore tried to identify TEAD binding sites in the 30
region of the intron 11. For Chip experiments the promoter of the
CTGF gene was chosen as a positive control. Q-PCR results
showed, as previously published [18], a speciﬁc chromatin bind-
ing site for TEAD1 and YAP proteins (data not shown) in CTGF
promoter. Chip experiments performed with the 30 region of the
intron 11 did not reveal any speciﬁc chromatin binding for TEAD1
protein. However, since the 4 putative binding sites with the
highest probability (more than 0.60) (Table S1A) are located in
the non-analyzable Alu repeated sequence (Fig. 4B) we carried
out electrophoretic mobility shift assays (EMSA). Of the four sites,
attention was focused on the two sites located in tandem at the 30
end of the Alu region (Fig. 4B, probes T1 and T2), since it has been
reported that the DNA binding afﬁnity of TEAD proteins is higher
with repeated tandem binding sites [36]. EMSA was employed
using custom oligonucleotide probes spanning T1 and/or T2 puta-
tive sites (Table S1C), and nuclear extracts from HeLa cells trans-
fected with control plasmid, TEAD1 or TEAD1 D55-121, a TEAD1
protein deleted of its TEA domain [11]. Cytoplasmic extract and
competition assays were performed to conﬁrm the speciﬁcity of
the TEAD1–DNA complexes (Fig. 4C). Nuclear extracts from cells
transfected with TEAD1 and oligonucleotide speciﬁc for the pro-
moter of the CTGF gene were used as a robust positive control
and revealed a retardation of the probe due to DNA/TEAD1 com-
plex (data not shown). Interestingly, when EMSA experiments
were performed with nuclear extracts from TEAD1 overexpress-
ing cells, we observed a retardation of the probe with oligonucle-
otides spanning TEAD1-like site T1–T2 (Fig. 4C) due to the
formation of DNA/TEAD1 complexes, but not with oligonucleo-
tides spanning only the T1 or T2 sites (data not shown). As ex-
pected, TEAD1 DNA-binding activity in nuclear extracts from
control or TEAD1 D55-121 was not observed with T1, T2 and
T1–T2 oligonucleotides (data not shown). Taken together, TEAD1
complexes binding on these TEAD1-like tandem sites T1–T2 sug-
gest that the expression of NAIP may be transcriptionally regu-
lated by TEAD1 binding to these sites located within this
intronic region in the gene locus.4. Discussion
Besides the well described anti-apoptotic functions of NAIP [2–
4], several studies propose NAIP as a regulator for inﬂammasome
formation that activates inﬂammatory caspases in response to dif-
ferent stimuli [8,9]. This process, well studied in mice, is also
known as ‘‘pyroptosis’’, that differs from apoptosis by the speciﬁc
activation of caspase-1 in response to intracytoplasmic pathogen-
associated molecular patterns by NOD-like receptors (NLR) leading
to the formation of a large pyroptosome (or inﬂammosome) in
macrophages [37]. Interestingly, a recent study showed that also
human NAIP is able to promote caspase-1 activation and subse-
quent pyroptosis in response infection in macrophage [38]. Since
the different domains of NAIP seem to be involved in different
functions, the existence of splicing variants described for its gene
could, at least partially, explain these different functions [10].
However, the events regulating NAIP transcription are largely
unknown.
Here we demonstrate, for the ﬁrst time, a positive regulation of
NAIP by TEAD1 which requires the interaction of TEAD1 with the
YAP cofactor, and this could be affected by the core components
of the Hippo pathway. Interestingly we identiﬁed a novel region
in the intron 11 responding to TEAD1/YAP activity, and to
TEAD1/YAP overexpression that could act as enhancer of NAIP
expression, as well as other putative regions in introns 3, 9 and
12. It is well known that enhancer sequences can also be found
within introns. In particular a recent study showed a possible link
between NF-jB activity and expression of NAIP potentially involv-
ing functional NF-jB binding sites in the promoter and in the sec-
ond intron of the NAIP gene [39]. In the present study, the
application of EMSA reveals TEAD1 DNA-binding to two previously
uncharacterized TEAD1 tandem regulatory binding elements in the
NAIP intron 11 regions, suggesting that TEAD1 can regulate the
transcription on the NAIP gene through cis-regulatory elements
that resemble the TEAD consensus binding motif.
Moreover, the consequences of TEAD1 and/or YAP overexpres-
sion on basal apoptosis in HeLa cells were investigated. As
showed in Fig. S1G, in TEAD1 overexpressing cells apoptosis
was slightly reduced, while NAIP expression is slightly induced
(Fig. S1F). Interestingly, when TEAD1 and YAP were co-transfec-
ted, a signiﬁcant decrease of apoptosis was observed, according
with the up-regulation of NAIP mRNA levels (Fig. S1F and G). Ta-
ken together, these results suggest a possible anti-apoptotic func-
tion of NAIP in HeLa cells. However further study are needed to
prove the effective role of NAIP in apoptosis protection in HeLa
cells.
At the present time, the biological signiﬁcance of our observa-
tions is necessarily speculative. However, since our data strongly
suggest that interaction of TEAD1 with YAP is required for NAIP
up-regulation, it will be interesting to investigate the physiological
role of this regulation in tissues where these proteins are ex-
pressed. Interesting potential candidates include mammalian pla-
centa, since it has been showed that NAIP is highly expressed in
human decidual cells of the decidua basalis, the maternal portion
of the placenta [40]. Importantly TEAD proteins as well as their
most studied cofactors YAP and the Vestigial-like proteins (Vgll1-
4), the mammalians homologues of the Drosophila transcriptional
co-activator Vestigial (Vg), are also expressed in the cells precursor
of the placenta or in mature placenta [41–43]. To better under-
stand the biological relevance of this new regulation, in physiolog-
ical or pathological conditions, as well as to assess a possible direct
link between the TEAD1/YAP transcription factor and the identiﬁed
intronic regions, further analyses are required to gain insight into
the physiological signiﬁcance of this new regulation of NAIP by
the TEAD1/YAP transcription factor.
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